Andrew helps some of the biggest brands in pharma to understand physician and patient behavior, providing them with the tools to drive behavioral change.
He is an expert in using research to explore how our unconscious biases affect the decisions we make every day. He spent a large portion of his career leading the government research team at Cello Health (now part of Lumanity), designing some of the UK Government’s largest research programs, using behavioral science to help shape the UK pension reforms, financial regulation and consumer protection. He has 20 government research publications to his name.
Since bringing this expertise to the healthcare sector, he has grown our dedicated behavioral science team, Disrupt, helping clients across therapy areas to build and maintain the success of their key products. He also specializes in quantitative research with a particular focus on large-scale tracking and segmentation projects.
Andrew holds a master's degree in Modern and Medieval Languages from the University of Cambridge.